Medical Affairs and Scientific Strategy
Strategic and operational medical affairs support including KOL engagement, scientific platform development, medical information, and promotional material review.
Quote thisMedical Affairs, Regulatory, and IP Consulting for Life Sciences
Serving pharmaceutical and biotech organizations across India, the United States, and the EU, from IND submission through post-approval compliance and patent protection.
13+
Service lines
FDA, EMA, CDSCO
Regulatory jurisdictions covered
India, United States, European Union
Active markets
HIPAA, GDPR, PDPA, DPDP
Data compliance frameworks
IndiaUnited StatesEuropean Union
Consulting Services
Medical Communications and Writing
Regulatory and scientific writing for submission-ready documents, publications, and training materials across the product lifecycle.
Quote thisRegulatory Affairs Advisory
Dossier preparation and submission strategy for FDA, EMA, and CDSCO, covering IND, NDA, ANDA, and BLA pathways through post-approval support.
Quote thisBiopharmaceutical IP and Patent Services
Full-scope IP strategy including patent search and analytics, freedom-to-operate analysis, AI-supported patent drafting, portfolio management, and trademark registration.
Quote thisClinical Research and CRO Integration
Integrated Sponsor-CRO-Site delivery model covering Phase I through IV, including protocol design, CRO oversight, site management, and pharmacovigilance.
Quote thisHealthcare Data Analytics, HEOR, and AI Tools
Real-world data and evidence strategy, health economics modeling, KOL analytics, and AI-assisted platforms for literature mining, medical writing, and patent search.
Quote thisWhy Organizations Choose LEELAWMED
Three disciplines, one engagement
Medical, legal, and regulatory expertise are delivered under a single consulting relationship, reducing the coordination overhead that multi-vendor models impose on regulated-industry clients.
Multi-jurisdiction regulatory coverage
The team works across FDA, EMA, and CDSCO submission requirements, enabling clients with concurrent US, EU, and India filing obligations to work from one advisory partner.
AI tools integrated with domain expertise
Proprietary AI-assisted platforms support patent search, literature mining, and NLP-based medical writing, applied by qualified consultants rather than as standalone software.
Phase I through commercialization continuity
Service coverage spans clinical protocol design, regulatory submission, post-approval compliance, and IP protection, so clients do not need to re-brief a new partner at each lifecycle stage.
Data privacy compliance built in
Healthcare data analytics and HEOR projects are structured against HIPAA, GDPR, PDPA, and India's DPDP Act from the outset, not added as a retrofit.